The Latest Breaking News on Pharma

A Relative Strength Rating upgrade for Recursion Pharma shows improving technical performance.

Record-high inflation, the Federal Reserve's hawkish stance, and growing recession fears have increased market volatility. Nevertheless, despite the unsettling macroenvironment, few stocks have delivered stable returns and could continue to beat the market based on their solid growth attributes. AbbVie Inc. (ABBV), J. Jill Inc. (JILL), and Bassett Furniture Industries…

Many pharmacies and physicians are forced to deny patients access to drugs, such as methotrexate, that can be used to help induce an abortion

BOSTON — Eight years after the ALS Ice Bucket Challenge went viral across social media and raised hundreds of millions of dollars for research, a Cambridge company is on the brink of a major breakthrough for ALS patients.

As demand for menopause drugs soars, we trace the oestrogen production line from Chinese soya bean fields to European pharmacy shelves

S&P 500 giant Eli Lilly leads five medical stocks setting up and showing relative strength in the ongoing bear market.

The application for children ages 6 months to under 6 years is expected to be completed later this year.

As billions of dollars in opioid lawsuit settlements are starting to flow to governments, families and advocates impacted by the opioid crisis are pushing for a meaningful say in how the money will be used

Biotech stock Timber Pharmaceuticals (TMBR) is down more than 70% year-to-date. Analysts expect it to keep reporting losses over the next two years. So, will it be wise to buy the stock now? Read on to learn our view….